Amy Lazar, MD
Otolaryngology · Bridgewater, NJNPI 1568441988
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations.
Across 150 payments — averaging $19.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$641
- Aerin Medical Inc.$387
- Regeneron Healthcare Solutions, Inc.$336
- Optinose US, Inc.$251
- GSK$226
- Stryker$146
- plus $918 from 22 others
What the payments were for
- Food & beverage$2,73494%
- Education$1726%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 38 | $641 |
| Aerin Medical Inc. | 16 | $387 |
| Regeneron Healthcare Solutions, Inc. | 21 | $336 |
| Optinose US, Inc. | 14 | $251 |
| GSK | 15 | $226 |
| Stryker | 3 | $146 |
| Sanofi-aventis U.S. LLC | 2 | $138 |
| Medtronic | 3 | $107 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $104 |
| Novartis | 4 | $75 |
| CSL Behring | 3 | $69 |
| Amgen | 3 | $66 |
| Alk-abello, Inc | 3 | $45 |
| Grifols USA, LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $42 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Incyte Corporation | 2 | $29 |
| Smith+Nephew | 1 | $21 |
| Acadia Pharmaceuticals Inc | 1 | $21 |
| Mimedx Group, Inc. | 1 | $19 |
| Acclarent, Inc | 1 | $18 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Shire North American Group Inc | 1 | $14 |
| Kaleo, Inc. | 1 | $13 |
| Olympus America Inc. | 1 | $13 |
| Phathom Pharmaceuticals, Inc. | 1 | $12 |
| Boehringer Ingelheim | 1 | $11 |
| Glenmark Therapeutics Inc. | 1 | $9 |
How this compares
$2,906 in reported general payments places this provider in the 75th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 143 | $4,893 |
| Azelastine Hcl | 123 | $3,990 |
| Azelastine-FluticasoneAzelastine/Fluticasone | 21 | $3,666 |
| Fluticasone Propionate | 152 | $2,233 |
| Mometasone Furoate | 14 | $1,463 |
| Fluocinolone Acetonide Oil | 36 | $1,073 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 11 | $1,028 |
| Montelukast Sodium | 83 | $956 |
| Omeprazole | 87 | $830 |
| Clotrimazole | 17 | $306 |
| Mupirocin | 51 | $298 |
| Ofloxacin | 12 | $232 |
| CefuroximeCefuroxime Axetil | 17 | $221 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 24 | $190 |
| Famotidine | 21 | $174 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Bridgewater
- Mena AbrahimBridgewater$3K
- Adrianna HekiertBridgewater$3K
- Nishant ReddyEast Windsor$133K
- Giant LinFlorham Park$25K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Andrew BlitzerHackensack$9K
- Ahmad MahmoudClifton$9K
- Jean EloyNewark$8K
- Ramtin KassirWayne$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.